
    
      This will be an open study conducted in healthy male subjects at a single centre. Each
      subject will participate in a screening visit and 2 study periods. At the first study period,
      all subjects will receive a single dose of BCT197 and at study period 2, all subjects will
      receive 3 daily doses of azithromycin and a single dose of BCT197.
    
  